Xiaorong Shui

639 total citations
31 papers, 492 citations indexed

About

Xiaorong Shui is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaorong Shui has authored 31 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaorong Shui's work include Pulmonary Hypertension Research and Treatments (7 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xiaorong Shui is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Xiaorong Shui collaborates with scholars based in China and United States. Xiaorong Shui's co-authors include Wei Lei, Yuan He, Can Chen, Shian Huang, Can Chen, Jianfeng Zhong, Wenjiang Chen, Zhiwen Chen, Jianxiong Li and Yi Tao and has published in prestigious journals such as Scientific Reports, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Xiaorong Shui

30 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaorong Shui China 12 234 97 83 66 51 31 492
Chunxiao Liang China 13 264 1.1× 79 0.8× 97 1.2× 58 0.9× 28 0.5× 28 572
Cátia V. Vaz Portugal 17 248 1.1× 154 1.6× 97 1.2× 55 0.8× 27 0.5× 34 669
Jiaojiao Liang China 13 277 1.2× 66 0.7× 48 0.6× 41 0.6× 40 0.8× 19 537
Noriko Kanaya United States 17 335 1.4× 113 1.2× 107 1.3× 28 0.4× 31 0.6× 27 715
Xiaoli Ren China 14 220 0.9× 79 0.8× 63 0.8× 30 0.5× 15 0.3× 42 518
Daorong Hou China 14 283 1.2× 87 0.9× 43 0.5× 49 0.7× 23 0.5× 26 619
Yiguan Zhang China 15 348 1.5× 93 1.0× 23 0.3× 50 0.8× 31 0.6× 34 621
Shian Huang China 11 135 0.6× 52 0.5× 101 1.2× 43 0.7× 12 0.2× 22 369
Yinggang Sun China 13 221 0.9× 108 1.1× 54 0.7× 81 1.2× 36 0.7× 40 718

Countries citing papers authored by Xiaorong Shui

Since Specialization
Citations

This map shows the geographic impact of Xiaorong Shui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Shui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Shui more than expected).

Fields of papers citing papers by Xiaorong Shui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Shui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Shui. The network helps show where Xiaorong Shui may publish in the future.

Co-authorship network of co-authors of Xiaorong Shui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Shui. A scholar is included among the top collaborators of Xiaorong Shui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Shui. Xiaorong Shui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuanqi, et al.. (2025). Potential role of AhR in ischemia‑reperfusion injury and cancers: Focus on ferroptosis and lipid peroxidation signaling pathways (Review). International Journal of Molecular Medicine. 56(4). 1–15.
2.
Wang, Zhiying, et al.. (2024). The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors. Frontiers in Oncology. 14. 1328606–1328606. 5 indexed citations
3.
4.
Chen, Meihong, Hui Li, Yun Li, et al.. (2024). Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review). International Journal of Molecular Medicine. 54(6). 5 indexed citations
5.
Zhang, Yuanqi, et al.. (2024). UA influences the progression of breast cancer via the AhR / p27 Kip1 /cyclin E pathway. The FASEB Journal. 38(18). e70058–e70058. 5 indexed citations
6.
Shui, Xiaorong, et al.. (2023). The potential relationship of coronary artery disease and hyperuricemia: A cardiometabolic risk factor. Heliyon. 9(5). e16097–e16097. 21 indexed citations
7.
He, Yuan, et al.. (2023). Aryl hydrocarbon receptor: A bridge linking immuno-inflammation and metabolism in atherosclerosis. Biochemical Pharmacology. 216. 115744–115744. 2 indexed citations
8.
Chen, Meihong, Jing Zheng, Xiaorong Shui, et al.. (2023). Insights into the relationship between serum uric acid and pulmonary hypertension (Review). Molecular Medicine Reports. 29(1). 5 indexed citations
9.
Zhu, Ying, Xiaorong Shui, Zheng Liang, et al.. (2020). Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review). International Journal of Molecular Medicine. 46(3). 936–948. 41 indexed citations
10.
Ye, Wenfeng, Shuyun Cai, Yuan He, et al.. (2020). Heart‑lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review). International Journal of Molecular Medicine. 46(3). 913–924. 2 indexed citations
11.
Chen, Can, et al.. (2018). MicroRNA-1 Regulates the Differentiation of Adipose-Derived Stem Cells into Cardiomyocyte-Like Cells. Stem Cells International. 2018. 1–13. 6 indexed citations
12.
Li, Guoming, et al.. (2017). <i>In silico</i> Analysis of 4CL Family in <i>Scutellaria baicalensis</i> through Biocomputational Tools and Servers. American journal of biochemistry & biotechnology. 13(1). 27–33. 1 indexed citations
13.
Huang, Shian, Wenjun Huang, Yuan He, et al.. (2017). Quercetin Inhibits Pulmonary Arterial Endothelial Cell Transdifferentiation Possibly by Akt and Erk1/2 Pathways. BioMed Research International. 2017. 1–8. 16 indexed citations
14.
He, Yuan, Jianfeng Zhong, Shian Huang, et al.. (2017). Elevated circulating miR-126-3p expression in patients with acute myocardial infarction: its diagnostic value.. PubMed. 10(11). 11051–11056. 12 indexed citations
15.
Lei, Wei, Yuan He, Xiaorong Shui, et al.. (2016). Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension. Molecular Medicine Reports. 14(5). 4383–4390. 30 indexed citations
16.
Lei, Wei, et al.. (2016). Determination of Abscisic Acid and its Relationship to Drought Stress Based on Cowpea Varieties with Different Capability of Drought Resistance. American journal of biochemistry & biotechnology. 12(1). 79–85. 9 indexed citations
17.
Huang, Shian, Xiaorong Shui, Yuan He, et al.. (2015). AhR expression and polymorphisms are associated with risk of coronary arterial disease in Chinese population. Scientific Reports. 5(1). 8022–8022. 48 indexed citations
18.
Shui, Xiaorong, et al.. (2015). Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor. Journal of Pharmacy and Pharmacology. 67(12). 1756–1764. 25 indexed citations
19.
Shui, Xiaorong, Zhiwen Chen, & Jianxiong Li. (2013). MicroRNA prediction and its function in regulating drought-related genes in cowpea. Plant Science. 210. 25–35. 29 indexed citations
20.
Lei, Wei, et al.. (2009). Compute simulation to characterize structure and function of chalcone synthase from Scutellaria baicalensis georgi. Molecular Biology. 43(6). 1008–1013. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunxiao Liang Breakdown of academic impact, for papers by Cátia V. Vaz Breakdown of academic impact, for papers by Jiaojiao Liang Breakdown of academic impact, for papers by Noriko Kanaya Breakdown of academic impact, for papers by Xiaoli Ren Breakdown of academic impact, for papers by Daorong Hou Breakdown of academic impact, for papers by Yiguan Zhang Breakdown of academic impact, for papers by Shian Huang Breakdown of academic impact, for papers by Yinggang Sun
Rankless by CCL
2026